trading.jeff It is I believe $ONCS 1st Patent. This is major for $ONCS as their new less-pain Electroporation device could be become "standard of care" when applying electrical voltage to the cancer tumors. This device in time could replace the "Inovio Device"
I believe the market is ignoring the facts on purpose to buy shares cheaply. I'm sure the next ASCO will give us exposure and this will take off and the market will be helpless to stop us anymore.
The survival data from hundreds of patients speaks for itself. I can't believe we are not FDA approved yet.
News 
Market Data 
Discover 
